| Patents for C07K - Peptides (3,738) |
|---|
| 12/18/2002 | EP1266965A2 Recombinant antibodies for human therapy |
| 12/18/2002 | EP0948349B1 in vitro methods and use of pharmaceutical compositions for the TREATMENT OF INNER EAR HAIR CELLS |
| 12/12/2002 | WO2002067848A3 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE |
| 12/11/2002 | EP1264599A1 TNF-derived peptides for use in treating oedema |
| 12/11/2002 | EP1263963A2 Corynebacterium glutamicum genes encoding proteins involved in carbon metabolism and energy production |
| 12/11/2002 | EP1263790A1 Monoclonal antibodies to the human ldl receptor, their production and use |
| 12/11/2002 | EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer |
| 12/11/2002 | CN1384757A Method for down-regulating GDF-8 activity |
| 12/10/2002 | CA2114015C Recombinant antibodies for human therapy |
| 12/04/2002 | EP1261718A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 12/03/2002 | CA2116120C Peptides having growth hormone releasing activity |
| 11/28/2002 | US20020176868 Isolation and characterization of the csa operon (ETEC-CS4 pili) and methods of using same |
| 11/27/2002 | EP0671928B1 Synthesis of n-substituted oligomers |
| 11/21/2002 | US20020173488 Boronic Ester and acid compounds, synthesis and uses |
| 11/21/2002 | US20020172988 Nucleotide sequences |
| 11/20/2002 | EP1258492A1 N-substituted oligomers and methods for their synthesis, e.g. polyglycine bearing nucleic acid bases |
| 11/20/2002 | EP1257649A2 Corynebacterium glutamicum genes encoding metabolic pathway proteins |
| 11/20/2002 | EP1257584A2 Humanized antibodies that sequester amyloid beta peptide |
| 11/13/2002 | EP1255839A2 Corynebacterium glutamicum genes encoding proteins involved in membrane synthesis and membrane transport |
| 11/07/2002 | US20020165342 Glucagon-like insulinotropic peptides, compositions and methods |
| 11/07/2002 | US20020165155 Crystallization of IGF-1 |
| 11/07/2002 | US20020164680 ErbB4 receptor-specific neuregulin related ligands and uses therefor |
| 11/06/2002 | EP1254232A2 Corynebacterium glutamicum genes encoding proteins involved in homeostasis and adaptation |
| 11/05/2002 | CA2147124C Erythropoietin analogs |
| 10/31/2002 | WO2002012502A3 Anti-tnf antibodies, compositions, methods and uses |
| 10/29/2002 | US6471500 Using a mammalian cell culture medium completely free of nonrecombinant mammalian proteins which are not derived from the host cells. |
| 10/24/2002 | US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto |
| 10/23/2002 | EP1251173A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 10/23/2002 | CN1376166A Peptide that lower blood glucose levels |
| 10/16/2002 | EP1248802A2 Soluble ctla4 mutant molecules and uses thereof |
| 10/16/2002 | EP0721343B1 Pharmaceutical formulations of nerve growth factor |
| 10/15/2002 | US6465433 Boronic ester and acid compounds, synthesis and uses |
| 10/10/2002 | US20020146771 Process for producing erythropoietin containing no animal proteins |
| 10/10/2002 | US20020146391 For diagnosis and therapy of susceptibility to atopic allergy, asthma |
| 10/09/2002 | EP1247531A2 TNF-derived peptides for use in treating oedema |
| 10/03/2002 | WO2002077017A2 Medical uses of intercellular communication facilitating compounds |
| 10/03/2002 | US20020142968 For therapeutic and/or prophylactic treatment of idiopathic and adult respiratory distress syndrome, pulmonary fibrosis following treatment with radiation or chemotherapy, septic shock, septicemia, inflammatory responses |
| 10/03/2002 | US20020142389 Soluble T cell receptor |
| 10/01/2002 | CA1341389C Human granulocyte colony stimulating factor |
| 09/26/2002 | WO2002074806A2 New interferon beta-like molecules |
| 09/26/2002 | WO2002074785A2 Method and composition for decreasing the tryptophan concentration in the blood of mammals |
| 09/26/2002 | WO2002016611A3 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 09/26/2002 | US20020137716 Administering nucleotide sequence |
| 09/26/2002 | CA2469846A1 New interferon beta-like molecules |
| 09/25/2002 | EP1243652A2 Glial derived neurotrophic factor |
| 09/25/2002 | EP1242448A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 09/25/2002 | EP0918540B1 Intradermal bovine polynucleotide vaccine |
| 09/24/2002 | US6455669 Glycoprotein for use in the treatment and prevention of bacterial infections |
| 09/18/2002 | EP1241258A2 Stem cell factor |
| 09/17/2002 | US6451770 A liquid jet intradermal administration apparatus that administers an immunogenic composition or vaccine to an animal: without a needle, and into the epidermis, dermis and/or hypodermis; wherein the apparatus includes an |
| 09/17/2002 | CA2080272C Cyclic vasoactive peptides |
| 09/12/2002 | WO2002016410A3 Peptide selection method |
| 09/12/2002 | US20020127601 Detecting modulators of g-protein coupled receptor activity; obtain cell containing g-protein coupled receptor pathway, incubate with modulator, determine quantative and qualitative effect of modulator on receptor |
| 09/11/2002 | EP1237915A2 Polynucleotid encoding the rg1 polypeptide |
| 09/11/2002 | CN1090506C Application of lysozyme dimer |
| 09/06/2002 | WO2002067848A2 PEPTIDES FROM THE 16/6id ANTIBODY FOR TREATING SLE |
| 09/03/2002 | US6444786 Bactericides |
| 08/29/2002 | WO2002066056A2 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/29/2002 | US20020119149 Multivalent T cell receptor complexes |
| 08/29/2002 | CA2440197A1 Synthetic vaccines comprising polyhydroxypolymer carriers |
| 08/22/2002 | WO2002064627A2 Crystallization of igf-1 |
| 08/22/2002 | WO2002064617A2 Method and system for haplotype reconstruction |
| 08/22/2002 | US20020115612 High-speed automated solid-phase synthesis repeating steps of acylation of a resin-bound secondary amine with haloacetic acid followed by nucleophilic displacement of the halogen by an N-substituted amine; libraries |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/20/2002 | CA2088367C Tri- and tetra-valent monospecific antigen-binding proteins |
| 08/20/2002 | CA2063886C Polyethylene protein conjugates |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | CA2438376A1 Method and apparatus for the production of antigens and uses thereof |
| 08/13/2002 | US6433143 Tie-2 ligands |
| 08/08/2002 | WO2002060950A2 Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 08/08/2002 | WO2002014347A3 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
| 08/08/2002 | US20020106743 IL-17 homologous polypeptides and therapeutic uses thereof |
| 07/31/2002 | CN1361823A Global regulators of bacterial pathogenic genes, bacterial autoinducer inactivation protein, as targets for engineering disease resistance |
| 07/25/2002 | US20020098169 Novel sequences and their use |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002022776A3 Human coagulation factor vii variants |
| 07/18/2002 | CA2434567A1 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/04/2002 | US20020086368 Human toll homologues |
| 07/03/2002 | CN1357045A Outer surface proteins, their genes, and their use |
| 07/02/2002 | CA2054699C Growth of vascular endothelial cell growth factor and dna encoding same |
| 06/27/2002 | WO2002022168A3 Vaccine against streptococcus pneumoniae |
| 06/27/2002 | WO2002022167A3 Vaccine against streptococcus penumoniae |
| 06/27/2002 | US20020081605 Method for detecting growth hormone variations in humans, the variations and their uses |
| 06/27/2002 | US20020081282 Genetically engineered cell comprising DNA encoding a transmembrane LAG-3 protein (lymphocyte activting gene) on its surface resulting in the protection from graft rejection by a host's immune system |
| 06/25/2002 | US6410513 Polypeptides |
| 06/25/2002 | US6410272 Production of thrombin inhibitors |
| 06/13/2002 | WO2002046237A2 Humanized antibodies that recognize beta amyloid peptide |
| 06/06/2002 | WO2000024782A3 Modified peptides, comprising an fc domain, as therapeutic agents |
| 06/04/2002 | US6399333 Process for producing erythropoietin containing no animal proteins |
| 05/30/2002 | US20020064833 Nucleotide sequences for use in the treatment of drug abuse and drug dependence |
| 05/30/2002 | US20020064533 HBV core antigen particles with multiple immunogenic components attached via peptide ligands |
| 05/21/2002 | US6392012 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/16/2002 | WO2002038601A2 Foggy |
| 05/16/2002 | US20020058617 Effective for reducing body mass and for treating obesity-related diseases and disorderssuch as hyperlipidemias, atherosclerosis, diabetes, and hypertension. |
| 05/16/2002 | CA2425980A1 Foggy |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/14/2002 | US6388053 Mixing glucagon-like peptide-1 with a divalent metal cation, then incubating to form a complex; antidiabetic agents |
| 05/10/2002 | WO2001092337A3 Soluble ctla4 mutant molecules and uses thereof |
| 05/10/2002 | WO2001085993A3 Method for detecting growth hormone variations in humans, the variations and their uses |
| 05/10/2002 | WO2001077145A3 Integrin binding peptide derivatives |